Cris Mons

Cris Mons

Auto-generated profile, based on publicly available information

Cris Mons


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
RBRianne Bouma
Rianne Bouma
HBHendrik J. Brink
Hendrik J. Brink
CMCris Mons
Cris Mons
JSJoeke G.C. Stolwijk
Joeke G.C. Stolwijk
VKVeronique A.L. Konijn
Veronique A.L. Konijn
AAAlsya Affandi
Alsya Affandi
Cancer vaccines' efficacy to stimulate T cell responses in patients is currently sub-optimal, and this can be potentially overcome by the delivery of antigens directly to antigen-presenting cells (APCs). To achieve this, single domain antibodies (nanobodies, Nbs) specific for receptors on APCs can be conjugated to liposomes to deliver cancer antigens. Here, we generated three CD169-specific Nb liposomes containing 3 different Nb clones (1B5, 1C1, and 2C2) and one CLEC9A-specific Nb liposome. Blocking experiments with CD169-specific antibodies indicated distinct binding epitopes on CD169 for 2C2 compared with 1B5 and 1C1. Both 2C2 and 1C1 Nb liposomes showed stronger binding and uptake by CD169-overexpressing cell lines and monocyte derived dendritic cells compared to 1B5 liposomes. Analysis of primary blood-derived APCs demonstrated strong uptake of 2C2 and 1C1 Nb liposomes by Axl+ Siglec-6+ DCs, classical monocytes, and DC3s, whereas CLEC9A-specific Nb liposomes were taken up by CLEC9A-expressing XCR1+ DC1s. In contrast, when gp100-specific T cell activation was evaluated using gp100-containing CD169-specific Nb liposomes and moDCs, only 1B5 Nb liposomes led to an enhanced T cell response. Using enriched blood DCs, we also observed an increased T cell activation by gp100-containing CLEC9A-specific Nb liposomes. To conclude, CD169- and CLEC9A-specific Nb liposomes are specifically taken up by primary CD169- or CLEC9A-expressing human APCs, and, depending on the Nb, can lead to a higher T cell activation. These results highlight the potential of Nb liposomes to improve vaccination strategies for immunotherapy.